The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Intracellular Angiotensin II Production in Diabetic Rats Is Correlated With Cardiomyocyte Apoptosis, Oxidative Stress, and Cardiac Fibrosis
Open accessAbstract
OBJECTIVE—Many of the effects of angiotensin (Ang) II are mediated through specific plasma membrane receptors. However, Ang II also elicits biological effects from the interior of the cell (intracrine), some of which are not inhibited by Ang receptor blockers (ARBs). Recent in vitro studies have identified high glucose as a potent stimulus for the intracellular synthesis of Ang II, the production of which is mainly chymase dependent. In the present study, we determined whether hyperglycemia activates the cardiac intracellular renin-Ang system (RAS) in vivo and whether ARBs, ACE, or renin inhibitors block synthesis and effects of intracellular Ang II (iAng II). RESEARCH DESIGN AND METHODS—Diabetes was induced in adult male rats by streptozotocin. Diabetic rats were treated with insulin, candesartan (ARB), benazepril (ACE inhibitor), or aliskiren (renin inhibitor). RESULTS—One week of diabetes significantly increased iAng II levels in cardiac myocytes, which were not normalized by candesartan, suggesting that Ang II was synthesized intracellularly, not internalized through AT1 receptor. Increased intracellular levels of Ang II, angiotensinogen, and renin were observed by confocal microscopy. iAng II synthesis was blocked by aliskiren but not by benazepril. Diabetes-induced superoxide production and cardiac fibrosis were partially inhibited by candesartan and benazepril, whereas aliskiren produced complete inhibition. Myocyte apoptosis was partially inhibited by all three agents. CONCLUSIONS—Diabetes activates the cardiac intracellular RAS, which increases oxidative stress and cardiac fibrosis. Renin inhibition has a more pronounced effect than ARBs and ACE inhibitors on these diabetes complications and may be clinically more efficacious.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Physiology of Local Renin-Angiotensin Systems
Paul, M., Poyan Mehr, A., & Kreutz, R. (2006) · Physiological Reviews · doi:10.1152/physrev.00036.2005 · Cited by 1,739
Nguyen, G., Delarue, F., Burcklé, C., Bouzhir-Sima, L., Giller, T., & Sraer, J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14276 · Cited by 1,276
Nguyen, G., Delarue, F., Burcklé, C., Bouzhir, L., Giller, T., & Sraer, J.-D. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214276 · Cited by 1,137
Myocardial Cell Death in Human Diabetes
Frustaci, A., Kajstura, J., Chimenti, C., Jakoniuk, I., Leri, A., Maseri, A., Nadal-Ginard, B., & Anversa, P. (2000) · Circulation Research · doi:10.1161/01.res.87.12.1123 · Cited by 796
Angiotensin Type 1 Receptor Blockers Induce Peroxisome Proliferator–Activated Receptor-γ Activity
Schupp, M., Janke, J., Clasen, R., Unger, T., & Kintscher, U. (2004) · Circulation · doi:10.1161/01.cir.0000127955.36250.65 · Cited by 705
Structure-based design of aliskiren, a novel orally effective renin inhibitor
Wood, J. M., Maibaum, J., Rahuel, J., Grütter, M. G., Cohen, N.-C., Rasetti, V., Rüger, H., Göschke, R., Stutz, S., Fuhrer, W., et al. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01451-7 · Cited by 506
Nussberger, J., Wuerzner, G., Jensen, C., & Brunner, H. R. (2002) · Hypertension · doi:10.1161/hy0102.102293 · Cited by 409
Kajstura, J., Fiordaliso, F., Andreoli, A. M., Li, B., Chimenti, S., Medow, M. S., Limana, F., Nadal-Ginard, B., Leri, A., & Anversa, P. (2001) · Diabetes · doi:10.2337/diabetes.50.6.1414 · Cited by 386
Increased Plasma Inactive Renin in Diabetes Mellitus: A Marker of Microvascular Complications
Luetscher, J. A., Kraemer, F. B., Wilson, D. M., Schwartz, H. C., & Bryer-Ash, M. (1985) · New England Journal of Medicine · doi:10.1056/nejm198505303122202 · Cited by 335
Myocyte Death in Streptozotocin-Induced Diabetes in Rats Is Angiotensin II- Dependent
Fiordaliso, F., Li, B., Latini, R., Sonnenblick, E. H., Anversa, P., Leri, A., & Kajstura, J. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780057 · Cited by 292
Feldman, D. L., Jin, L., Xuan, H., Contrepas, A., Zhou, Y., Webb, R. L., Mueller, D. N., Feldt, S., Cumin, F., Maniara, W., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.108845 · Cited by 283
Nguyen, G., Delarue, F., Berrou, J., Rondeau, E., & Sraer, J.-D. (1996) · Kidney International · doi:10.1038/ki.1996.511 · Cited by 241
Feldt, S., Batenburg, W. W., Mazak, I., Maschke, U., Wellner, M., Kvakan, H., Dechend, R., Fiebeler, A., Burckle, C., Contrepas, A., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.101444 · Cited by 236
Prorenin Induces Intracellular Signaling in Cardiomyocytes Independently of Angiotensin II
Saris, J. J., ’t Hoen, P. A. C., Garrelds, I. M., Dekkers, D. H. W., den Dunnen, J. T., Lamers, J. M. J., & Jan Danser, A. H. (2006) · Hypertension · doi:10.1161/01.hyp.0000240064.19301.1b · Cited by 232
Vidotti, D. B., Casarini, D. E., Cristovam, P. C., Leite, C. A., Schor, N., & Boim, M. A. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00371.2003 · Cited by 224
Determinants of angiotensin II generation during converting enzyme inhibition.
Juillerat, L., Nussberger, J., Ménard, J., Mooser, V, Christen, Y., Waeber, B., Graf, P., & Brunner, H. R. (1990) · Hypertension · doi:10.1161/01.hyp.16.5.564 · Cited by 212
Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice
Lu, H., Rateri, D. L., Feldman, D. L., Jr., R. J. C., Fukamizu, A., Ishida, J., Oesterling, E. G., Cassis, L. A., & Daugherty, A. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32970 · Cited by 208
Mackins, C. J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25713 · Cited by 195
van Kats, J. P., de Lannoy, L. M., Danser, A. H. J., van Meegen, J. R., Verdouw, P. D., & Schalekamp, M. A. D. H. (1997) · Hypertension · doi:10.1161/01.hyp.30.1.42 · Cited by 188
Singh, V. P., Baker, K. M., & Kumar, R. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.91493.2007 · Cited by 176
Self-citationThe Collecting Duct Is the Major Source of Prorenin in Diabetes
Kang, J. J., Toma, I., Sipos, A., Meer, E. J., Vargas, S. L., & Peti-Peterdi, J. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.107268 · Cited by 173
Evidence of a novel intracrine mechanism in angiotensin II-induced cardiac hypertrophy
Baker, K. M., Chernin, M. I., Schreiber, T., Sanghi, S., Haiderzaidi, S., Booz, G. W., Dostal, D. E., & Kumar, R. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.04.004 · Cited by 158
Self-citationWood, J. M., Schnell, C., Cumin, F., Ménard, J., & Webb, R. L. (2005) · Journal of Hypertension · doi:10.1097/00004872-200502000-00025 · Cited by 156
Westermann, D., Rutschow, S., Linthout, S. V., Linderer, A., Bücker-Gärtner, C., Sobirey, M., Riad, A. H., Pauschinger, M., Schultheiß, H., & Tschöpe, C. (2006) · Diabetologia · doi:10.1007/s00125-006-0385-2 · Cited by 156
In Vitro Evidence for an Intracellular Site of Angiotensin Action
Cook, J. L., Zhang, Z., & Ré, R. N. (2001) · Circulation Research · doi:10.1161/hh2401.101270 · Cited by 144
Mannose 6-Phosphate Receptor–Mediated Internalization and Activation of Prorenin by Cardiac Cells
van Kesteren, C. A. M., Danser, A. H. J., Derkx, F. H. M., Dekkers, D. H. W., Lamers, J. M. J., Saxena, P. R., & Schalekamp, M. A. D. H. (1997) · Hypertension · doi:10.1161/01.hyp.30.6.1389 · Cited by 142
Singh, V., Le, B., Bhat, V. B., Baker, K. M., & Kumar, R. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00391.2007 · Cited by 140
Self-citationvan de Wal, R. M. A., Plokker, H. W. M., Lok, D. J. A., Boomsma, F., van der Horst, F. A. L., van Veldhuisen, D. J., van Gilst, W. H., & Voors, A. A. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.02.016 · Cited by 135
The intracellular renin–angiotensin system: a new paradigm
Kumar, R., Singh, V., & Baker, K. M. (2007) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2007.05.001 · Cited by 131
Self-citationMechanism of High Glucose–Induced Angiotensin II Production in Rat Vascular Smooth Muscle Cells
Lavrentyev, E. N., Estes, A. M., & Malik, K. U. (2007) · Circulation Research · doi:10.1161/circresaha.107.151852 · Cited by 128
The intracellular renin–angiotensin system: implications in cardiovascular remodeling
Kumar, R., Singh, V., & Baker, K. M. (2008) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3282f521a8 · Cited by 127
Self-citationFunctional Significance of Prorenin Internalization in the Rat Heart
Peters, J., Farrenkopf, R., Clausmeyer, S., Zimmer, J., Kantachuvesiri, S., Sharp, M. G. F., & Mullins, J. J. (2002) · Circulation Research · doi:10.1161/01.res.0000019242.51541.99 · Cited by 120
Involvement of chymase-mediated angiotensin II generation in blood pressure regulation
Li, M., Liu, K., Michalicek, J., Angus, J. A., Hunt, J. E., Dell’Italia, L. J., Feneley, M. P., Graham, R. M., & Husain, A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20805 · Cited by 114
High Plasma Prorenin in Diabetes Mellitus and Its Correlation with Some Complications
Franken, A. A. M., Derkx, F. H. M., VELD, A. J. M. I., Hop, W. C. J., van Rens, G. H. M. B., PEPERKAMP, E. D., de Jong, P. T. V. M., & Schalekamp, M. A. D. H. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-4-1008 · Cited by 108
Aksnes, T. A., Kjeldsen, S. E., Rostrup, M., Omvik, P., Hua, T. A., & Julius, S. (2007) · Hypertension · doi:10.1161/hypertensionaha.106.085654 · Cited by 107
Characterization of the Angiotensin II Receptor Antagonist TCV-116 in Healthy Volunteers
Delacrétaz, E., Nussberger, J., Biollaz, J., Waeber, B., & Brunner, H. R. (1995) · Hypertension · doi:10.1161/01.hyp.25.1.14 · Cited by 93
Watanabe, T., Suzuki, J., Yamawaki, H., Sharma, V. K., Sheu, S., & Berk, B. C. (2005) · Circulation · doi:10.1161/circulationaha.104.509760 · Cited by 92
Koka, V., Wang, W., Huang, X. R., Kim‐Mitsuyama, S., Truong, L. D., & Lan, H. Y. (2006) · Circulation · doi:10.1161/circulationaha.105.575589 · Cited by 81
Okin, P. M., Devereux, R. B., Gerdts, E., Snapinn, S. M., Harris, K. E., Jern, S., Kjeldsen, S. E., Julius, S., Edelman, J. M., Lindholm, L. H., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.574822 · Cited by 81
Circulating versus tissue renin-angiotensin system: On the origin of (pro)renin
Krop, M., & Danser, A. H. J. (2008) · Current Hypertension Reports · doi:10.1007/s11906-008-0022-1 · Cited by 80
Intracellular angiotensin II induces cell proliferation independent of AT1 receptor
Baker, K. M., & Kumar, R. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00238.2006 · Cited by 70
Self-citationWeber, M. A., & Giles, T. D. (2006) · PubMed · Cited by 55
Ficociello, L., Perkins, B. A., Silva, K. H., Finkelstein, D. M., Ignatowska-Switalska, H., Gaciong, Z. A., Cupples, L. A., Aschengrau, A., Warram, J. H., & Królewski, A. S. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03691106 · Cited by 54
Cristovam, P. C., Arnoni, C. P., de Andrade, M. C. C., Casarini, D. E., Pereira, L. G., Schor, N., & Boim, M. A. (2008) · Experimental Biology and Medicine · doi:10.3181/0708-rm-229 · Cited by 52
Intracellular Sorting of Renin: Cell Type Specific Differences and their Consequences
Peters, J., & Clausmeyer, S. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2002.2079 · Cited by 49
FATE OF [125I]ANGI0TENSIN II IN ADRENAL ZONA GLOMERULOSA CELLS
Bianchi, C. F., Gutkowska, J., Léan, A. D., Ballak, M., Anand‐Srivastava, M. B., Genest, J., & Cantin, M. (1986) · Endocrinology · doi:10.1210/endo-118-6-2605 · Cited by 47
Raimondi, L., Paoli, P. D., Mannucci, E., Lonardo, G., Sartiani, L., Banchelli, G., Pirisino, R., Mugelli, A., & Cerbai, E. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1927 · Cited by 42
Yoshiyama, M., Nakamura, Y., Omura, T., Izumi, Y., Matsumoto, R., Oda, S., Takeuchi, K., Kim, S., Iwao, H., & Yoshikawa, J. (2005) · Heart · doi:10.1136/hrt.2004.035618 · Cited by 28
Secretory and cytosolic (pro)renin in kidney, heart, and adrenal gland
Peters, J. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0328-0 · Cited by 23
Angiotensin II and the Cardiac Complications of Diabetes Mellitus
Connelly, K. A., Boyle, A., & Kelly, D. J. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207781662984 · Cited by 20
Hong, Y., Dingemanse, J., & Mager, D. E. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100495 · Cited by 19
Okazaki, Y., Yamasaki, Y., Uchida, H. A., et al. (2007) · Clinical and Experimental Nephrology · doi:10.1007/s10157-006-0456-1 · Cited by 18
Why Is Blood Pressure So Hard to Control in Patients With Type 2 Diabetes?
Kazuo Eguchi MD, P., Pickering, T. G., & Kario, K. (2007) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4564.2007.06124.x · Cited by 16
Cited by
Diretrizes Brasileiras de Hipertensão Arterial – 2020
Barroso, W. K. S., Rodrigues, C. I. S., Bortolotto, L. A., Mota-Gomes, M. A., Brandão, A. A., Feitosa, A. D. D. M., Machado, C. A., Poli-de-Figueiredo, C. E., Amodeo, C., Mion, D., et al. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20201238 · Cited by 1,068
Molecular mechanisms of diabetic cardiomyopathy
Bugger, H., & Abel, E. D. (2014) · Diabetologia · doi:10.1007/s00125-014-3171-6 · Cited by 903
Basic Mechanisms of Diabetic Heart Disease
Ritchie, R. H., & Abel, E. D. (2020) · Circulation Research · doi:10.1161/circresaha.120.315913 · Cited by 708
VI Diretrizes Brasileiras de Hipertensão
(2010) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2010001700001 · Cited by 596
Huynh, K., Bernardo, B. C., McMullen, J. R., & Ritchie, R. H. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.01.003 · Cited by 553
Metadata
- Authors
- Singh, V. P., Le, B., Khode, R., Baker, K. M., & Kumar, R.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2008-12-01
- Volume
- 57
- Issue
- 12
- Pages
- 3297-3306
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2112333460
- Cited by
- 332
- References
- 54
- FWCI
- 14.52
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.